2019
DOI: 10.1016/j.dsx.2019.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Ambivalence about the selection of cardiovascular risk stratification tools: Evidence in a type 1 diabetes population

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
2
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 24 publications
0
2
0
1
Order By: Relevance
“…In particular, the timing for initiating statin therapy needs further investigation. The STENO score could assist in better assessing the CV risk profile in patients with T1D, and in determining the eligibility for statin use [11].…”
Section: Type 1 Diabetes and CV Risk Evaluation: More Precision Neededmentioning
confidence: 99%
See 1 more Smart Citation
“…In particular, the timing for initiating statin therapy needs further investigation. The STENO score could assist in better assessing the CV risk profile in patients with T1D, and in determining the eligibility for statin use [11].…”
Section: Type 1 Diabetes and CV Risk Evaluation: More Precision Neededmentioning
confidence: 99%
“…However, there seems to be substantial heterogeneity in CV risk in T1D [7,8]. Therefore, it is crucial to accurately assess CV risk in patients with T1D and there is growing research interest into CV risk stratification tools [8][9][10][11].…”
Section: Introductionmentioning
confidence: 99%
“…Entre las complicaciones crónicas de la DM, las úlceras del pie, también conocidas como pie diabético, y la amputación de las extremidades son las más graves y implican un mayor impacto socioeconómico. Las úlceras del pie tienen una incidencia anual del 2%, siendo que una persona con diabetes presenta un riesgo del 25% de desarrollar úlceras del pie durante toda la vida (10)(11)(12) .…”
Section: Introductionunclassified